Novo Nordisk's pricing methods while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of rate gouging, pointing out the stark contrast between U.S. selling prices and people in Europe and copyright.In Oct 2024, Novo Nordisk revealed a research on scientific journal Character about a novel gluco… Read More